Author

Alireza Rahimi

Scripps Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1

Frequent Co-Authors

Amal Gebara-LambiD· 2 shared Anil K. Sen GuptaiD· 2 shared Arnab K. ChatterjeeiD· 2 shared Ashley K. Woods· 2 shared Case W. McNamaraiD· 2 shared Frank O. WeissiD· 2 shared Gennadii A. GrabovyiiD· 2 shared James R. PedroarenaiD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Amal Gebara-LambORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pan-Coronavirus Protease Engagement and Differentiated Pharmacology of Antiviral Candidate CMX990

N. G. R. Dayan Elshan, Karen C. Wolff, Laura Riva, Malina A. Bakowski, Simeon Babarinde, Anshul Chaudhary, Mark Zeller, Ashley K. Woods, Gennadii A. Grabovyi, Katy B. Wilson, Rebecca A. Leonard, Briana Lynn McGovern, Jared Benjamin, Isidora D. Suazo, Mary Gordon, , Arnab K. Chatterjee

This study evaluates CMX990, a coronavirus Mpro inhibitor, showing broad antiviral activity against multiple coronaviruses and superior pharmacologic properties compared to existing inhibitors.

bioRxiv · Oct 1, 2026 · PreprintPharmacology & Toxicology

Orally Bioavailable SARS-CoV-2 Protease Inhibitors Bearing a Hydroxymethyl Ketone Warhead

N. G. R. Dayan Elshan, Karen C. Wolff, Frank O. Weiss, Sourav Ghorai, Gennadii A. Grabovyi, Katy Wilson, Laura Riva, Ashley K. Woods, James R. Pedroarena, Armen Nazarian, Yuyin Liu, Wrickban Mazumdar, Lirui Song, Neechi Okwor, Jacqueline Malvin, , Arnab K. Chatterjee

This paper describes the development of orally bioavailable SARS-CoV-2 protease inhibitors with a hydroxymethyl ketone warhead, showing improved potency and bioavailability compared to previous compounds.

Viruses · Jul 26, 2026Peer-reviewedPharmacology & Toxicology